MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


FTSE turns negative, led by GlaxoSmithKline

StockMarketWire.com

UK stocks fell into the red by close on Wednesday, led by a big fall from pharmaceutical giant GlaxoSmithKline.

Having been in positive territory for most of the day, buoyed by vaccine and US stimulus optimism, the benchmark FTSE 100 index closed 0.14% lower to 6,507.82.

The index was not helped by one of its constituents, pharmaceutical company GlaxoSmithKline, which dropped 6.29% to £12.82 as disruptions caused by the coronavirus pandemic led GSK to forecast a mid-to-high single digit decline in 2021 adjusted earnings, compared to the 3% drop expected by analysts.

But on a positive note for the company, it announced that it had formed a €150 million collaboration with CureVacto to develop mRNA-based Covid-19 vaccines, by 2022.

GlaxoSmithKline said it also would support the manufacture of up to 100 million doses of CureVac's first generation Covid-19 vaccine candidate.

Telecom bellwether Vodafone had initially helped the FTSE 100 record solid gains as it increased 5.87% to 134.86p even as it reported a 4.1% fall in third-quarter revenue, pinned on lower international roaming due to the pandemic.

But what pleased investors was that it also posted a small rise in organic services revenue -- a closely watched measure -- and reaffirmed full-year adjusted earnings guidance of between €14.4 billion and €14.6 billion.

Elsewhere, miner and commodities trader Glencore gained 0.87% to 248.95p, having left its annual production guidance for 2021 unchanged. For 2020 it reported substantial falls in copper and cobalt output, pinned on the closure of its Mutanda mine in the Democratic Republic of Congo.

Fellow miner Anglo American edged 0.47% higher to £24.40 as the value of rough diamond sales at its De Beers rose during the first cycle of 2021 rose to $650 million.

Student accommodation provider Unite shed 5.54% to 930p after it extended a 50% rent discount for students to seven weeks from four, in light of the UK's latest national Covid-19 lockdown.

Unite said the loss of rental income associated with the additional three-week rental discount was up to £6 million.

Budget carrier Wizz Air gained 3.73% to £47.88 despite announcing that it carried 82% less passengers during the month of January year-on-year, as the pandemic continued to hurt travel markets.

Food court and publishing group Time Out added 1.4% to 36p following news that it had agreed with developer Aldar Properties to open a new market on Abu Dhabi's Saadiyat Island.

The food market was expected to open in 2023 and would be Time Out's second in the United Arab Emirates, with a Dubai market set to open in the first half of 2021.

Out-of-hospital services provider Totally gained 5.86% to 34.3p after urgent care and planned care divisions won a further contract extension and new contract, respectively.

Immunotherapy developer Scancell slumped 5.26% to 13.5p on announcing that its vaccine partnership with charity Cancer Research UK had been terminated by mutual agreement.

Scancell cited the impact of the Covid-19 pandemic and Cancer Research UK's 're-evaluation of their collaboration model', for the decision. It would explore options to advance the programme either in house or with another partner.

Story provided by StockMarketWire.com